For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
Avadel Pharmaceuticals plc (NASDAQ: AVDL) closed the day trading at $8.05 up 2.94% from the previous closing price of $7.82. In other words, the price has increased by $2.94 from its previous closing price. On the day, 1.83 million shares were traded. AVDL stock price reached its highest trading level at $8.34 during the session, while it also had its lowest trading level at $7.78.
Ratios:
For a better understanding of AVDL, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.60 and its Current Ratio is at 2.97. In the meantime, Its Debt-to-Equity ratio is 0.49 whereas as Long-Term Debt/Eq ratio is at 0.48.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Rodman & Renshaw on June 12, 2024, initiated with a Buy rating and assigned the stock a target price of $27.
On March 05, 2024, Oppenheimer reiterated its Outperform rating and also lowered its target price recommendation from $27 to $29.
Needham reiterated its Buy rating for the stock on March 05, 2024, while the target price for the stock was revised from $20 to $22.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 13 ’25 when Thornton Peter J. bought 10,000 shares for $8.04 per share. The transaction valued at 80,450 led to the insider holds 104,055 shares of the business.
Ende Eric J bought 30,000 shares of AVDL for $235,218 on Jan 13 ’25. The Director now owns 208,900 shares after completing the transaction at $7.84 per share. On Dec 13 ’24, another insider, MCHUGH THOMAS S, who serves as the Chief Financial Officer of the company, bought 2,300 shares for $10.44 each. As a result, the insider paid 24,019 and bolstered with 87,800 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AVDL now has a Market Capitalization of 775710144 and an Enterprise Value of 748157312. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.61 while its Price-to-Book (P/B) ratio in mrq is 10.39. Its current Enterprise Value per Revenue stands at 5.415 whereas that against EBITDA is -12.066.
Stock Price History:
The Beta on a monthly basis for AVDL is 1.34, which has changed by -0.49187785 over the last 52 weeks, in comparison to a change of 0.23147523 over the same period for the S&P500. Over the past 52 weeks, AVDL has reached a high of $19.09, while it has fallen to a 52-week low of $7.39. The 50-Day Moving Average of the stock is -29.04%, while the 200-Day Moving Average is calculated to be -43.98%.
Shares Statistics:
Over the past 3-months, AVDL traded about 1.39M shares per day on average, while over the past 10 days, AVDL traded about 1976090 shares per day. A total of 96.34M shares are outstanding, with a floating share count of 88.15M. Insiders hold about 8.52% of the company’s shares, while institutions hold 74.86% stake in the company. Shares short for AVDL as of 1735603200 were 11770961 with a Short Ratio of 8.46, compared to 1732838400 on 9786822. Therefore, it implies a Short% of Shares Outstanding of 11770961 and a Short% of Float of 13.969999999999999.
